Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.52 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
| ▸ | AHR | P35869 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9927345 | 0.92 | NQO2 (0.85) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL2756741 | 0.92 | NQO2 (0.85) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL21131352 | 0.90 | NQO2 (0.81) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL12355721 | 0.82 | NQO2 (0.70) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL12355722 | 0.82 | NQO2 (0.70) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL30745612 | 0.82 | NQO2 (0.70) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL434975 | 0.82 | NQO2 (0.70) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL17483584 | 0.82 | NQO2 (0.68) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL17483582 | 0.82 | NQO2 (0.68) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL13770454 | 0.82 | NQO2 (0.68) | NQO2ALDH1A1KDM4EL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2995601-B1 | METHOD OF INHIBITING POLYMERIZATION OF AROMATIC VINYL COMPOUND | HAKUTO KK (JP) | 2017-02-01 | — | — | EP | claimed |
| EP-2995601-A1 | METHOD OF INHIBITING POLYMERIZATION OF AROMATIC VINYL COMPOUND | Hakuto Co., Ltd (JP) | 2016-03-16 | — | — | EP | claimed |
| US-20090149682-A1 | Process for Inhibiting Polymerization of an Aromatic Vinyl Compound | HAKUTO CO., LTD. (JP) | 2009-06-11 | — | — | US | claimed |
| EP-2000451-A9 | METHOD OF INHIBITING POLYMERIZATION OF AROMATIC VINYL COMPOUND | Hakuto Co., Ltd (JP) | 2009-03-25 | — | — | EP | claimed |
| EP-2000451-A2 | METHOD OF INHIBITING POLYMERIZATION OF AROMATIC VINYL COMPOUND | Hakuto Co., Ltd (JP) | 2008-12-10 | — | — | EP | claimed |
| US-4925901-A | STORAGE STAABILITY, ONIUM ION CATALYST | THE DOW CHEMICAL COMPANY (US) | 1990-05-15 | — | — | US | claimed |
| CN-114717047-A | Water-substitution-method stone-milled peanut oil production process | 河南粒粒熟食品有限公司 | 2022-07-08 | — | — | CN | disclosed |
| WO-2021135182-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | 陕西莱特光电材料股份有限公司 | 2021-07-08 | — | — | WO | disclosed |
| WO-2019149260-A1 | PYRIDAZINOL COMPOUND, DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | 青岛清原化合物有限公司 | 2019-08-08 | — | — | WO | disclosed |
| US-20180159141-A1 | Non-Platinum Group Oxygen Reduction Reaction Catalysts | BATTELLE SAVANNAH RIVER ALLIANCE, LLC | 2018-06-07 | — | — | US | disclosed |
| EP-2170975-B1 | COMPOSITIONS AND METHODS FOR PRODUCING CELLULAR LABELS FOR NUCLEAR MAGNETIC RESONANCE TECHNIQUES | UNIV CARNEGIE MELLON (US) | 2018-05-02 | — | — | EP | disclosed |
| EP-2995601-B1 | METHOD OF INHIBITING POLYMERIZATION OF AROMATIC VINYL COMPOUND | HAKUTO KK (JP) | 2017-02-01 | — | — | EP | disclosed |
| EP-2995601-A1 | METHOD OF INHIBITING POLYMERIZATION OF AROMATIC VINYL COMPOUND | Hakuto Co., Ltd (JP) | 2016-03-16 | — | — | EP | disclosed |
| US-5169473-A | Complex of an onium, arsenic or amine compound and boric acid; advanced polyepoxides; storage stability | THE DOW CHEMICAL COMPANY (US) | 1992-12-08 | — | — | US | disclosed |
| US-5134239-A | Quaterinary indolizine compound | THE DOW CHEMICAL COMPANY (US) | 1992-07-28 | — | — | US | disclosed |
| EP-0458502-A2 | Latent catalysts, cure-inhibited epoxy resin compositions and laminates prepared therefrom | THE DOW CHEMICAL COMPANY (US) | 1991-11-27 | — | — | EP | disclosed |
| US-4925901-A | STORAGE STAABILITY, ONIUM ION CATALYST | THE DOW CHEMICAL COMPANY (US) | 1990-05-15 | — | — | US | disclosed |
| EP-0328020-A2 | Use of a catalyst in epoxy compositions | THE DOW CHEMICAL COMPANY (US) | 1989-08-16 | — | — | EP | disclosed |
| US-4792521-A | Non-enzymatic immunohistochemical staining system and reagents | IMMUNOMEDICS, INC. (US) | 1988-12-20 | — | — | US | disclosed |
| EP-0250676-A2 | Non-enzymatic immunohistochemical staining system and reagents | Immunomedics, Inc. (US) | 1988-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149682-A1 | Process for Inhibiting Polymerization of an Aromatic Vinyl Compound | VCP, PAH, VIM | NQO2 2092/4885ALDH1A1 1616/4885KDM4E 342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.